Lawrence A. Leiter
St. Michael's Hospital(CA)University of Toronto(CA)Merck Institute for Science Education(US)Institute for Clinical Evaluative Sciences(CA)
Publications by Year
Research Areas
Diabetes Treatment and Management, Lipoproteins and Cardiovascular Health, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes(2016)6,312 cited
- → Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes(2018)6,145 cited
- → Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus(2013)3,444 cited
- → Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,888 cited
- → SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials(2018)2,745 cited
- → Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome(2012)2,011 cited